Preclinical scientific tests propose that retatrutide may well influence obesity-connected cancer progression. In a analyze led by Marathe et al., retatrutide-induced weight-loss diminished tumor engraftment, delayed tumor onset, and considerably attenuated tumor advancement in pancreatic and lung cancer products, with larger tumor suppression comp